MODD Overview

Modular Medical, Inc. is a medical device company. The Company is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. The Company's product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include three parts - one reusable, two disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; removable system, slim profile, lighter weight, and no external controller required, no charging and no battery replacement. Its pump product comprises the pump, a disposable cartridge that holds the insulin reservoir, a baseplate that affixes the pump product to the user's body and the infusion set, which includes a cannula to infuse the insulin into the body.

Wall Street analysts forecast MODD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MODD is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Modular Medical Inc revenue for the last quarter amounts to -7.24M USD, increased 49.24

Modular Medical Inc. EPS for the last quarter amounts to -8377000.00 USD, increased 80.62

Modular Medical Inc (MODD) has 54 emplpoyees as of June 01 2026.

Today MODD has the market capitalization of 26.95M USD.